Event Details

News & Events

News Releases
Events & Presentations

Canaccord 45th Annual Growth Conference

August 13, 2025 | 9:30 AM EDT

Webcast

Investor Contact

Kevin Gardner
Investor relations on behalf of Eupraxia Pharmaceuticals

draftskgardner@lifesciadvisors.com
draftsinvestors@eupraxiapharma.com

phone_iphone +617-283-2856

Subscribe to our Email Alerts

Email Address Required

Eupraxia is a clinical-stage biotechnology company developing targeted therapies that leverage a proprietary extended-release delivery system to provide the right dose of a drug in the right place for the right amount of time.

Vancouver lab & office:
Eupraxia Pharmaceuticals
2198 Yukon St,
Vancouver, BC, V5Y 3P1
Canada

Get in Touch

Contact
Careers
250-590-3968

Follow us on :

Privacy Policy
Term of Use
IR Email Alerts

Search Investors

Search this site